Interviews With Cannabis Executives, Investors, Celebrities & Policy Makers

02:58pm ET11/29/2023
Open Book Extracts (OBX), a cannabinoid product manufacturer, has inked a term sheet to acquire Nucl3o, a processor of high-purity cannabinoid isolates, Benzinga Cannabis has learned exclusively.
Read More
01:00pm ET11/29/2023
Austin-based ketamine therapy provider Mindbloom is launching its Mastermind Series, the first-of-its-kind, expert-led psychedelic therapy program for overcoming severe mental and emotional health challenges.
Read More
11:53pm ET11/28/2023
In an exclusive interview with Benzinga, BDSA analyst Brendan Mitchel-Chesebro provided a detailed analysis of Ohio's emerging recreational cannabis market.
Read More
11:42pm ET11/28/2023
"Much like the plant, the future of cannabis is female. I absolutely see major growth over the next 2-4 years, albeit slowly in terms of cannabis funding.
Read More
01:31pm ET11/28/2023
Beckley Retreats, a science-backed psilocybin retreats and holistic wellbeing company, is officially launching its Signature Program for Personal Discovery and Transformation, “an 11-week curriculum of preparation and integration support to help guests achieve the most significant benefit from their six-day psilocybin retreats” in Jamaica and the Ne
Read More
01:30pm ET11/28/2023
Legendary boxing champion Mike Tyson and Carma HoldCo Inc. announced on Tuesday that they will debut of their Tyson 2.0 cannabis brand in New York via a partnership with Hudson Cannabis.
Read More
01:00pm ET11/28/2023
Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy.
Read More